Finally, Kunderfranco et al. demonstrated that EHF contributes to tumour suppression of prostate cancer cells by repressing expression of EZH2 and promoting expression of the tumour suppressor Nkx3.1 [83]. The gene discussed is NKX3-1; the disease is neoplasm.